Martha A.
Martha A. Barajas-Torres, Santa Rosa, CA US
Patent application number | Description | Published |
---|---|---|
20130253344 | INTRAVASCULAR IMPLANTABLE MEDICAL DEVICE INTRODUCTION - In one example, this disclosure is directed to a kit for intravascular implantation of an implantable medical device within a patient, the kit comprising an elongated outer sheath forming an inner lumen with a distal opening, the outer sheath sized to traverse a vasculature of the patient, and an elongated inner sheath with an inflatable member at its distal portion. The inflatable member is inflatable from a proximal end of the inner sheath to close-off the distal opening of the outer sheath when inflated. The inner sheath further includes a stopper proximally located relative to the inflatable member. The inflatable member is remotely controllable from a proximal end of the inner sheath to retract in a proximal direction towards the stopper. The inflatable member can be retracted in a proximal direction towards the stopper and past an implantable medical device positioned within a distal portion of the outer sheath. | 09-26-2013 |
20130253345 | IMPLANTABLE MEDICAL DEVICE DELIVERY CATHETER WITH TETHER - In one example, this disclosure is directed to a kit for intravascular implantation of an implantable medical device within a patient, the kit comprising an elongated outer sheath forming an inner lumen with a distal opening, the outer sheath sized to traverse a vasculature of the patient, and an elongated inner sheath with an enlarged distal portion, wherein the enlarged distal portion is configured to substantially fill the inner lumen and close-off the distal opening of the outer sheath. The enlarged distal portion is slidable relative to the outer sheath. The inner sheath further includes a tether with a helical element that is remotely controllable from a proximal end of the inner sheath to release the implantable medical device from a distal portion of the outer sheath. | 09-26-2013 |
Martha A. Crisler, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20120245811 | TRANSMISSION SYSTEMS AND METHODS - A method includes: receiving M solenoids, each marked with a unique one of M identifiers, where M is an integer greater than one; receiving M lookup tables associated with respective ones of the M identifiers, wherein each of the M lookup tables establishes a relationship between input current and output pressure for only one of the M solenoids; assembling a transmission with a selected one of the M solenoids; selecting one of the M lookup tables based on one of the M identifiers marked on the selected one of the M solenoids; storing the selected one of the M lookup tables in memory of a transmission control module of a vehicle that is assembled with the transmission; and controlling output pressure of the selected one of the M solenoids based on the selected one of the M lookup tables and the input current using the transmission control module. | 09-27-2012 |
Martha A. Maselko, Belmar, NJ US
Patent application number | Description | Published |
---|---|---|
20120279083 | Flip-flop 4-season fashion shoe - A flip-flop sandal shoe construction with a fabric, fur or like overlay detachably secured to the front end of the flip-flop strap to provide a fashion statement of coloration, picturization or design to the sandal when wrapped around a wearer's foot and secured, or extending to the side edges of the sandal while continuing to provide an open toe presentation in allowing for pedicure servicing without first having to remove a sock or boot worn as a protective measure. | 11-08-2012 |
Martha A. Mercaldi, Concord, MA US
Patent application number | Description | Published |
---|---|---|
20080229293 | Data Reporting Application Programming Interfaces in an XML Parser Generator for XML Validation and Deserialization - A method for interfacing with an XML (Extensible Markup Language) parser generator to generate deserialization information interleaved with XML parsing and validation, including: providing an XML parser generator with information about the schema which the instance data conforms to; providing a data reporting application programming interface (API) and a generator module; providing one or more implementations of the data reporting API; providing the XML parser generator with a selected data reporting API implementation module; generating an XML parser to parse and validate instance documents conforming to the specified input schema and deserializing the instance documents into the desired deserialization format during the parse. | 09-18-2008 |
Martha A. Mutschler-Chu, Ithaca, NY US
Patent application number | Description | Published |
---|---|---|
20090029937 | BIODEGRADABLE CATIONIC POLYMER GENE TRANSFER COMPOSITIONS AND METHODS OF USE - The invention provides biodegradable, cationic compositions based on cationic α-amino acid-containing PEA, PEUR and PEU polymers for use in preparation of non-viral gene transfer compositions. In the invention gene transfer compositions a poly nucleic acid is condensed with the polymer to form a soluble unit wherein the electrical charge of the poly nucleic acid is neutralized by the polymers. The invention gene transfer compositions can be used to transfect target cells by contact with the target cells. | 01-29-2009 |
20100263067 | Methods and compositions for acylsugars in tomato - The present invention relates to tomato plants with increased concentrations of acylsugars, in particular increased concentrations of acylglucoses and/or acylsucroses. The present invention also provides methods for controlling thrips on tomato plants through the use of increased concentrations of acylsugars. | 10-14-2010 |
20120135054 | Poly (Ester Ether Amide)s and Uses Thereof - Cationic poly(ester ether amide)s (PEEAs) and compositions comprising PEEAs and biomolecules such as nucleic acids and proteins. Also, a method for intracellular delivery of biomolecules using complexes of the PEEAs and biomolecules. For example, PEEAs can be used as transfection agents for nucleic acids such as DNA and RNA. | 05-31-2012 |
Martha A. Sarpong, Collegeville, PA US
Patent application number | Description | Published |
---|---|---|
20080300239 | QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS - Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives. | 12-04-2008 |
20100234386 | QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS - Invented is a method of inhibiting the activity/function of PI3 kinases using quinoxaline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoxaline derivatives. | 09-16-2010 |
20120165321 | QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS - Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives. | 06-28-2012 |
20140296224 | QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS - Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives. | 10-02-2014 |
Martha A. Truninger, Corvallis, OR US
Patent application number | Description | Published |
---|---|---|
20090046130 | Electrostatic Actuator And Fabrication Method - In one embodiment a method of making an electrostatic actuator includes: forming a first conductor over a first substrate to form a first structure; forming a flexible second conductor over a second substrate to form a second structure; forming an etch stop over the first conductor as part of the first structure or over the second conductor as part of the second structure; forming a spacer on the etch stop, the spacer selectively etchable with respect to the etch stop; etching the spacer through to the etch stop at a location of a gap between the first conductor and the second conductor; and bonding the first structure and the second structure together such that the first conductor is located opposite the second conductor across the gap. | 02-19-2009 |
20110285794 | FLUID EJECTOR STRUCTURE - In one embodiment, a fluid ejector structure includes: a chamber for containing a fluid; a flexible membrane forming one wall of the chamber; a plurality of piezoelectric elements; a backing operatively connected to the piezoelectric elements such that an expansion and/or contraction of a piezoelectric element causes the piezoelectric element to bend; a rigid plate overlaying a center portion of the membrane; a post coupling the piezoelectric elements to the plate through the backing such that a movement of each piezoelectric element toward the chamber is transmitted to the plate through the post. The plate is configured to transmit movement of the post to the membrane in a rigid, or substantially rigid, piston-like manner. | 11-24-2011 |
Martha A. Warpehoski, Portage, MI US
Patent application number | Description | Published |
---|---|---|
20090291970 | Substituted Aminoethers for the Treatment of Alzheimer's Disease - The invention provides compounds of formula (I): useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation. | 11-26-2009 |